StockData

Nu-Med Plus, Inc. (NUMD) stock

NUMDOTCGold and Silver OresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 3/30
$0.01−0.00 (-8.16%)

Close on Oct 19, 2026Market cap $601.55KP/E –Yield –

Nu-Med Plus r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2013 it was $66.21K, up 199.2% from the year before.

Annual r&d expenses

PeriodPeriod endValueChange
FY2013Dec 31, 2013$66.21K+199.2%
FY2012Dec 31, 2012$22.13K–

More Nu-Med Plus figures

See a number that looks wrong?